Clinical trial
On the Cyberknife Dose Fraction of Liver Cancer Treatment
NCT03295500 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- On the Cyberknife Dose Fraction of Liver Cancer Treatment
- Lead sponsor
- Beijing 302 Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2017
- Completion date
- September 24, 2021
- Enrollment
- 657 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cyberknife radiosurgery